{"cik":2130606,"taxonomy":"us-gaap","tag":"EarningsPerShareBasic","label":"Earnings Per Share, Basic","description":"The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.","entityName":"OBSIDIAN THERAPEUTICS, INC.","units":{"USD/shares":[{"start":"2024-01-01","end":"2024-12-31","val":-6.47,"accn":"0001193125-26-374729","fy":null,"fp":null,"form":"S-1","filed":"2026-08-28","frame":"CY2024"},{"start":"2025-01-01","end":"2025-06-30","val":-3.72,"accn":"0001193125-26-374729","fy":null,"fp":null,"form":"S-1","filed":"2026-08-28"},{"start":"2025-04-01","end":"2025-06-30","val":-1.93,"accn":"0001193125-26-374729","fy":null,"fp":null,"form":"S-1","filed":"2026-08-28","frame":"CY2025Q2"},{"start":"2025-01-01","end":"2025-12-31","val":-7.22,"accn":"0001193125-26-374729","fy":null,"fp":null,"form":"S-1","filed":"2026-08-28","frame":"CY2025"},{"start":"2026-01-01","end":"2026-06-30","val":-2.3,"accn":"0001193125-26-374729","fy":null,"fp":null,"form":"S-1","filed":"2026-08-28"},{"start":"2026-04-01","end":"2026-06-30","val":-1.19,"accn":"0001193125-26-374729","fy":null,"fp":null,"form":"S-1","filed":"2026-08-28","frame":"CY2026Q2"}]}}